These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7903244)

  • 21. Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):719-28. PubMed ID: 23750681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of left ventricular hypertrophy is a key goal of hypertension management.
    Zhang R; Crump J; Reisin E
    Curr Hypertens Rep; 2003 Aug; 5(4):301-8. PubMed ID: 12844464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium antagonists in the treatment of hypertension in patients with ischaemic heart disease.
    Rosendorff C
    Expert Opin Pharmacother; 2003 Sep; 4(9):1535-41. PubMed ID: 12943483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
    Krauser DG; Devereux RB
    Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertensive heart disease--significance of left ventricular hypertrophy.
    Schmieder RE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertensive left ventricular hypertrophy: pathophysiology, assessment and treatment.
    Otterstad JE; Smiseth O; Kjeldsen SE
    Blood Press; 1996 Jan; 5(1):5-15. PubMed ID: 8777473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network.
    Izzo R; Losi MA; Stabile E; Lönnebakken MT; Canciello G; Esposito G; Barbato E; De Luca N; Trimarco B; de Simone G
    Hypertension; 2017 Jan; 69(1):136-142. PubMed ID: 27895192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional myocardial ischaemia and diastolic dysfunction in hypertensive heart disease.
    López Sendón J
    Eur Heart J; 1993 Nov; 14 Suppl J():110-3. PubMed ID: 8281954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta blockers & left ventricular hypertrophy regression.
    George T; Ajit MS; Abraham G
    Indian Heart J; 2010; 62(2):139-42. PubMed ID: 21180305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension.
    Clement DL; De Buyzere M; Duprez D
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):14S-19S. PubMed ID: 8466720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of Beta-Blocker in Patients with Hypertensive Left Ventricular Hypertrophy and Myocardial Ischemia.
    Koracevic G; Mićić S; Stojanovic M; Bozinovic N; Simic D; Lović D; Krstic N; Tomašević RJ
    Curr Vasc Pharmacol; 2023; 21(2):81-90. PubMed ID: 36722475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of essential hypertension today. The role of beta blockers, calcium antagonists, and ACE inhibitors.
    Lund-Johansen P
    Med Clin North Am; 1987 Sep; 71(5):947-57. PubMed ID: 2887720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular hypertrophy sensitizes the myocardium to the development of ischaemia.
    Salcedo EE; Marwick TH; Korzick DH; Goormastic M; Go RT
    Eur Heart J; 1990 Nov; 11 Suppl G():72-8. PubMed ID: 2150039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality.
    Kaplinsky E
    Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():549-56. PubMed ID: 7841088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension and left ventricular hypertrophy: is drug therapy beneficial?
    Eselin JA; Carter BL
    Pharmacotherapy; 1994; 14(1):60-88. PubMed ID: 8159603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.